A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

A Rutgers Cancer Institute study in Cell Reports Medicine promises help with both those problems. It identifies a protein ...

Tumors adapt to their environment to avoid detection. As different cancer treatments progress, tumors mutate and become resistant. Various markers are expressed on tumors that can be used to target in ...

Neuroblastoma, a pediatric cancer of the nervous system, remains the leading cause of cancer-related death in young children, particularly when the disease has spread. Despite aggressive treatment ...

Laboratory automation and artificial intelligence. Image by EasyLabAuto - Own work, CC BY-SA 4.0. Laboratory automation and artificial intelligence. Image by EasyLabAuto - Own work, CC BY-SA 4.0. In a ...

"Circulating tumor cells (CTCs), which are cancer cells found in the blood, are one of the main targets used to evaluate cancer patients' blood samples," states Miyuki Tabata, first author of the ...

When doctors are examining suspected cancer cases, they turn to biomarker tests to help make a diagnosis. With a testing system and patient samples, physicians can investigate potential leads, ...

Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...

Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the ...

Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data Using a training/validation study design, ...